RECURSION PHARMACEUT

RXRX

Delayed - 05/18 03:55:07 pm
5.615USD	-8.10%

Turn to zoom

Prev.	6.1100
Open	5.8300
High	6.0300
Low	5.4916
Volume	613 245

7d ago	North American Morning Briefing: All Eyes on Key -2-
7d ago	Recursion Pharmaceuticals: Q1 Earnings Snapshot
7d ago	RECURSION PHARMACEUTICALS, INC. Management's Discussion and Analysis of...
7d ago	RECURSION PHARMACEUTICALS, INC. : Results of Operations and Financial...

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bearish	Bearish
Resistance	7,73	11,0	17,1
Spread/Res.	-27%	-49%	-67%
Spread/Supp.	12%	12%	-0,35%
Support	5,04	5,04	5,64

Sales 2022	43,7 M - -
Net income 2022	-220 M - -
Net cash 2022	264 M - -
P/E ratio 2022	-3,81x
Yield 2022	-

Capitalization	1 051 M 1 051 M -
EV / Sales 2022	18,0x
EV / Sales 2023	16,3x
Nbr of Employees	450
Free-Float	87,6%

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company decoding biology by integrating technology across biology, chemistry, automation, machine learning, and engineering to industrialize drug discovery. The Companyâ€™s platform includes the Recursion Operating System, which...

>> Read more

Sector :

Bio Therapeutic Drugs

Calendar :

2022-06-14 Shareholder meeting

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	5
Last Close Price	6,11 $
Average target price	16,00 $
Spread / Average Target	162%